Jpmorgan Chase & CO Merck & Co., Inc. Transaction History

Jpmorgan Chase & CO

$1.27 Trillion
Q1 2025

A detailed history of Jpmorgan Chase & CO transactions in Merck & Co., Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 28,508,222 shares of MRK stock, worth $2.17 Billion. This represents 0.2% of its overall portfolio holdings.

Number of Shares

28,508,222

Previous 27,109,855 5.16%

Holding current value

$2.17 Billion

Previous $2.7 Billion 5.12%

% of portfolio

0.2%

Previous 0.22%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 12, 2025	BUY	$83.01 - $101.02 $116 Million - $141 Million	1,398,367 Added 5.16%	28,508,222 $2.56 Billion
Q4 2024 Feb 12, 2025	SELL	$96.31 - $114.76 $17 Million - $20.2 Million	-176,010 Reduced 0.65%	27,109,855 $2.7 Billion
Q3 2024 Dec 26, 2024	SELL	$111.15 - $128.97 $89 Million - $103 Million	-801,113 Reduced 2.85%	27,285,865 $3.1 Billion
Q3 2024 Nov 08, 2024	SELL	$111.15 - $128.97 $112 Million - $129 Million	-1,003,852 Reduced 3.61%	26,840,342 $3.05 Billion
Q2 2024 Dec 26, 2024	BUY	$123.8 - $132.96 $154 Million - $166 Million	1,246,636 Added 4.64%	28,086,978 $3.48 Billion
Q2 2024 Aug 12, 2024	BUY	$123.8 - $132.96 $146 Million - $157 Million	1,183,277 Added 4.44%	27,844,194 $3.45 Billion
Q1 2024 Dec 26, 2024	SELL	$113.24 - $131.95 $20.3 Million - $23.7 Million	-179,425 Reduced 0.67%	26,660,917 $3.52 Billion
Q1 2024 May 10, 2024	BUY	$113.24 - $131.95 $142 Million - $165 Million	1,251,014 Added 4.92%	26,660,917 $3.52 Billion
Q4 2023 Dec 26, 2024	SELL	$100.18 - $109.02 $94.6 Million - $103 Million	-943,824 Reduced 3.52%	25,896,518 $2.82 Billion
Q4 2023 Feb 12, 2024	BUY	$100.18 - $109.02 $246 Million - $268 Million	2,456,096 Added 10.7%	25,409,903 $2.77 Billion
Q3 2023 Nov 14, 2023	SELL	$102.95 - $114.33 $114 Million - $127 Million	-1,109,509 Reduced 4.61%	22,953,807 $2.36 Billion
Q2 2023 Aug 11, 2023	BUY	$108.61 - $118.38 $473 Million - $515 Million	4,350,744 Added 22.07%	24,063,316 $2.78 Billion
Q1 2023 May 18, 2023	BUY	$102.94 - $114.86 $123 Million - $137 Million	1,193,280 Added 6.44%	19,712,572 $2.1 Billion
Q1 2023 May 11, 2023	SELL	$102.94 - $114.86 $543 Million - $606 Million	-5,276,049 Reduced 22.17%	18,519,292 $1.97 Billion
Q4 2022 Feb 13, 2023	BUY	$87.44 - $112.11 $26.7 Million - $34.2 Million	305,417 Added 1.3%	23,795,341 $2.64 Billion
Q3 2022 Nov 14, 2022	BUY	$84.53 - $94.96 $64.2 Million - $72.2 Million	760,074 Added 3.34%	23,489,924 $2.02 Billion
Q2 2022 Aug 11, 2022	BUY	$83.49 - $94.64 $306 Million - $347 Million	3,668,227 Added 19.24%	22,729,850 $2.07 Billion
Q1 2022 May 11, 2022	BUY	$73.51 - $82.4 $64.8 Million - $72.6 Million	881,291 Added 4.85%	19,061,623 $1.56 Billion
Q4 2021 Feb 10, 2022	BUY	$72.28 - $90.54 $65.9 Million - $82.5 Million	911,398 Added 5.28%	18,180,332 $1.39 Billion
Q3 2021 Nov 12, 2021	BUY	$71.68 - $78.83 $1.24 Billion - $1.36 Billion	17,268,934 New	17,268,934 $1.3 Billion

Others Institutions Holding MRK

# of Institutions

3,893

Shares Held

1.93B

Call Options Held

26.2M

Put Options Held

23.5M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $193B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Account

Jpmorgan Chase & CO Merck & Co., Inc. Transaction History